Home > Archive>Volume 17, Issue 6, 2015 >634-637. DOI:10.7499/j.issn.1008-8830.2015.06.021
PDF HTML XML Export Cite reminder
Efficacy and safety of tyrosine kinase inhibitor dasatinib plus chemotherapy in the treatment of childhood Philadelphia chromosome–positive acute lymphoblastic leukemia
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
    • |
  • Figures
    • |
  • Metrics
    • |
  • Reference
    • |
  • Related
    • |
  • Cited by
    • |
  • Materials
    • |
  • Comments
    Abstract:

    No abstract available

    Reference
    Related
    Cited by
Get Citation

郭晔, 刘天峰, 杨文钰, 王书春, 阮敏, 陈晓娟, 张丽, 刘芳, 邹尧, 竺晓凡.达沙替尼联合化疗治疗儿童Ph阳性急性淋巴细胞白血病的疗效及安全性[J].中国当代儿科杂志英文版,2015,17(6):634-637

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 03,2014
  • Revised:December 14,2014
  • Adopted:
  • Online: June 15,2015
  • Published:
Article QR Code
External Links
You are the th visitor ICP:湘ICP备17021739号-4
® 2025 All Rights Reserved
Supported by:Beijing E-Tiller Technology Development Co., Ltd.
Administrator login